Cleared Traditional

3nethra neo (K183059) - FDA 510(k) Clearance

Class II Ophthalmic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K183059 · Forus Health Pvt.Ltd · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
49d
Days
Class 2
Risk

K183059 is an FDA 510(k) clearance for the 3nethra neo. Classified as Camera, Ophthalmic, Ac-powered (product code HKI), Class II - Special Controls.

Submitted by Forus Health Pvt.Ltd (Bengaluru, IN). The FDA issued a Cleared decision on December 21, 2018 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1120 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Forus Health Pvt.Ltd devices

Submission Details

510(k) Number K183059 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 02, 2018
Decision Date December 21, 2018
Days to Decision 49 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 110d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HKI Camera, Ophthalmic, Ac-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HKI Camera, Ophthalmic, Ac-powered

All 34
Devices cleared under the same product code (HKI) and FDA review panel - the closest regulatory comparables to K183059.
KOWA DR-1a
K190573 · Kowa Company , Ltd. · Jun 2019
Microperimeter MP-3, Microperimeter MP-3 Type S
K190198 · Nidek Co., Ltd. · Apr 2019
NFC-700 non-mydriatic auto fundus camera
K182199 · Crystalvue Medical Corporation · Jan 2019
LipiScan Dynamic Meibomian Imager
K182506 · Tearscience, Inc. · Dec 2018
RetCam 3
K182263 · Natus Medical Incorporated · Sep 2018
RetiCapture
K173474 · Ilooda Co,., Ltd. · Jul 2018